Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis

被引:0
|
作者
Lena Öhman
Anders Lasson
Anna Strömbeck
Stefan Isaksson
Marcus Hesselmar
Magnus Simrén
Hans Strid
Maria K. Magnusson
机构
[1] University of Gothenburg,Department of Microbiology and Immunology, Institute for Biomedicine, Sahlgrenska Academy
[2] University of Gothenburg,Department of Internal Medicine and Clinical Nutrition, Institute for Medicine, Sahlgrenska Academy
[3] Södra Älvsborg Hospital,Department of Internal Medicine
[4] University of North Carolina at Chapel Hill,Center for Functional Gastrointestinal and Motility Disorders
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Patients with ulcerative colitis (UC) have an altered gut microbiota composition, but the microbial relationship to disease activity needs to be further elucidated. Therefore, temporal dynamics of the fecal microbial community during remission and flare was determined. Fecal samples were collected at 2–6 time-points from UC patients during established disease (cohort EST) and at diagnosis (cohort NEW). Sampling range for cohort EST was 3–10 months and for cohort NEW 36 months. Relapses were monitored for an additional three years for cohort EST. Microbial composition was assessed by Genetic Analysis GA-map Dysbiosis Test, targeting ≥ 300 bacteria. Eighteen patients in cohort EST (8 with maintained remission and 10 experiencing a flare), provided 71 fecal samples. In cohort NEW, 13 patients provided 49 fecal samples. The microbial composition showed no clustering related to disease activity in any cohort. Microbial dissimilarity was higher between than within patients for both cohorts, irrespective of presence of a flare. Microbial stability within patients was constant over time with no major shift in overall composition nor modification in the abundance of any specific species. Microbial composition was not affected by intensified medical treatment or linked to future disease course. Thus in UC, the gut microbiota is highly stable irrespective of disease stage, disease activity or treatment escalation. This suggests that prolonged dietary interventions or repeated fecal transplantations are needed to be able to induce permanent alterations of the gut microbiota.
引用
收藏
相关论文
共 50 条
  • [1] Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
    Ohman, Lena
    Lasson, Anders
    Strombeck, Anna
    Isaksson, Stefan
    Hesselmar, Marcus
    Simren, Magnus
    Strid, Hans
    Magnusson, Maria K.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] Unstable fecal microbiota in ulcerative colitis during remission
    Martinez, Cristina
    Antolin, Maria
    Santos, Javier
    Torrejon, Antonio
    Casellas, Francesc
    Borruel, Natalia
    Guarner, Francisco
    Malagelada, Juan-Ramon
    GASTROENTEROLOGY, 2006, 130 (04) : A359 - A359
  • [3] Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission
    Martinez, Cristina
    Antolin, Maria
    Santos, Javier
    Torrejon, Antonio
    Casellas, Francesc
    Borruel, Natalia
    Guarner, Francisco
    Malagelada, Juan-R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (03): : 643 - 648
  • [4] Fecal microbiota transplantation and ulcerative colitis remission: A meta analysis
    Mirghani, Hyder Osman
    AlShalawi, Abdulaziz Abdullah
    Algabri, Mohammad Omar
    Albalawi, Turki Suleman
    Albalawi, Ahmed Mohammed F.
    Albalawi, Abdulaziz Nasser Saleh
    Alzamhari, Omar Sabah
    Alshahrani, Muteb Muflih M.
    Albalawi, Mohammed Ahmed I.
    Alquthami, Hatem Hamad Mohammed
    Albalawi, Waleed Muslih B.
    MEDICAL SCIENCE, 2022, 26 (130)
  • [5] The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis
    Saleh, Adam
    Parsa, Shyon
    Garza, Manuel
    Quigley, Eamonn M. M.
    Abraham, Bincy P.
    DIGESTIVE DISEASES, 2023, 41 (04) : 656 - 665
  • [6] The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis
    Magnusson, Maria K.
    Strid, Hans
    Isaksson, Stefan
    Simren, Magnus
    Ohman, Lena
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (06) : 956 - 966
  • [7] Improving remission rates in newly diagnosed paediatric ulcerative colitis
    Ashton, James J.
    Beattie, R. Mark
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 838 - 839
  • [8] Granulocyte-monocyte apheresis for remission in newly diagnosed ulcerative colitis
    Rolandsdotter, J.
    Browaldh, L.
    Hellberg, C.
    Finkel, Y.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S432 - S432
  • [9] Disease Activity Is Associated with Obesity in Newly Diagnosed Pediatric Patients with Ulcerative Colitis
    Kadenczki, Orsolya
    Dezsofi, Antal
    Cseh, Aron
    Szucs, Daniel
    Vass, Noemi
    Nemes, Eva
    Tarnok, Andras
    Szakos, Erzsebet
    Guthy, Ildiko
    Kovacs, Marta
    Karoliny, Anna
    Czelecz, Judit
    Kiss, Csongor
    Mueller, Katalin Eszter
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [10] Induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis in patients treated with MMXΘ mesalamine: established versus newly diagnosed disease
    Kamm, M.
    Sandborn, W.
    Lichtenstein, G.
    Solomon, D.
    Karlstadt, R.
    Barrett, K.
    Abhyankar, B.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S34 - S34